RESEARCH PAPER ANALYSIS
The impact of focused federal initiatives on pediatric cancer research.
AI interpretation is pending for this paper.
Open original publication →EXECUTIVE SUMMARY
What the AI sees
Not AI summarized yet.
WHY IT MATTERS
Research significance
Pending deeper interpretation.
ABSTRACT
Source abstract
Federal initiatives, including the Childhood Cancer Data Initiative and the Childhood Cancer Survivorship, Treatment, Access, and Research Act, are advancing pediatric cancer data sharing and strengthening infrastructure required for clinical trials, biobanking, and biospecimen collection. These efforts aim to transform pediatric cancer research to ultimately improve treatment outcomes, quality of life, and survivorship.
SUPPORTING PAPER SET
32 more papers to review
1
Comparison of Phenol Application and Endoscopic Pilonidal Sinus Treatment in Pediatric Pilonidal Sinus Disease.
Pediatrics international : official journal of the Japan Pediatric Society
63.74
2
Unfinished Business and Experiences of Bereaved Families of Patients with Cancer: A Cross-Sectional Survey.
Palliative medicine reports
61.0
3
The 21st International ``Ponte di Legno'' Childhood Acute Lymphoblastic Leukemia Workshop Report: Progress and Emerging Opportunities.
Clinical lymphoma, myeloma & leukemia
49.0
4
Acute Leukemia During the First Six Months of Life: A Population-Based Analysis of Survival by Leukemia Type.
Clinical lymphoma, myeloma & leukemia
64.12
5
Pediatric orbital solitary fibrous tumor/hemangiopericytoma presenting with isolated eyelid edema: a case report.
Frontiers in pediatrics
53.1
6
Malignancies in patients with inborn errors of immunity: insights from 20-years of clinical experience in Qatar.
Frontiers in immunology
68.6
7
Precision medicine and parental experience: a longitudinal study of psychosocial responses to germline genomic results in pediatric oncology.
Frontiers in medicine
67.36
8
Cytokine-augmented risk stratification for six-month incident nephritis in children with IgA vasculitis.
Frontiers in pediatrics
58.5
9
Time-bounded uncertainty in childhood cancer survivorship: a psycho-oncology perspective on result communication.
Frontiers in psychology
57.0
10
"From misdiagnosis to precision medicine: strengthening pediatric neuro-oncology care in LMICs toward equitable pLGG outcomes".
Frontiers in oncology
75.5
11
Practical Guidance on Initiating and Switching Targeted Immunotherapies in Generalised Myasthenia Gravis: A German-Austrian Expert Opinion Paper.
European journal of neurology
66.4
12
Technical Considerations for Robotic Pediatric Lobectomy.
Annals of thoracic surgery short reports
54.0
13
Kaposi Sarcoma-Associated Herpesvirus Is Not Detected in Osteosarcoma From KSHV-Endemic African Countries and the Non-Endemic United States Populations.
Journal of medical virology
59.5
14
ELISA (Embedding-Linked Interactive Single-cell Agent): an interpretable hybrid generative Artificial Intelligence agent for expression-grounded discovery in single-cell genomics.
Briefings in bioinformatics
48.5
15
Thyroid Cancer in the Modern Era: From Molecular Landscape and Multimodal Diagnostics to Integrative Traditional Chinese Medicine-A Comprehensive Review.
Cancer management and research
90.6
16
Presumed left atrial myxoma presenting with seizures, massive stroke, and systemic embolization in an adolescent: a case report.
International journal of emergency medicine
49.0
17
Ewing's Sarcoma in Adults: A Predictive Nomogram and Survival Analysis of a Cohort of 937 Patients.
Journal of surgical oncology
73.92
18
Comments on "Initial Cerebrospinal Fluid Blast Clearance Rate in Pediatric B-Lymphoblastic Leukemia Is Associated With Overall Survival".
Journal of pediatric hematology/oncology
49.12
19
Impact of Number of Lymph Nodes Sampled and Density of Positive Nodes on Outcomes Among Over 2000 Patients With Stage I to III Favorable Histology Wilms Tumor Enrolled on AREN03B2: A Children's Oncology Group Renal Tumor Study.
Annals of surgery
70.5
20
Prognostic impact of risk organ involvement and metabolic parameters assessed by staging 18F-FDG PET/CT in pediatric Langerhans cell histiocytosis.
Nuclear medicine communications
63.3
21
Prognostic value of plasma thymus- and activationregulated chemokine levels after the second cycle of chemotherapy in pediatric Hodgkin lymphoma.
Haematologica
55.44
22
Germline lymphoma-predisposing variants: impact on age of cancer diagnosis and survival in pediatric patients.
Haematologica
51.12
23
Excess mortality convergence after paediatric allogeneic transplantation: a caveat for the right to be forgotten. Comment on: "Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia".
Haematologica
49.5
24
EARLY DISCONTINUATION OF ANTIBIOTICS IN PEDIATRIC PATIENTS WITH LOW- AND HIGH-RISK FEBRILE NEUTROPENIA: A SINGLE-CENTRE EXPERIENCE.
Journal of the Pediatric Infectious Diseases Society
68.4
25
Comment on "How I Approach Anxiety in Children and Teens with Cancer".
Pediatric blood & cancer
47.5
26
Progressive Tracheal Injury Following Tumor Regression in a Child With T-Cell Lymphoblastic Lymphoma.
Pediatric blood & cancer
28.5
27
Very Late Relapse of Acute Myeloid Leukemia With a Rare HNRNPH1::MLLT10 Fusion Following a Pediatric Myeloid Neoplasm: A Successful Venetoclax-Azacitidine Bridge to Hematopoietic Stem Cell Transplantation.
Pediatric blood & cancer
49.12
28
Interventions to Reduce Financial Toxicity of Childhood, Adolescent, and Young Adult Cancer Survivors: A Scoping Review.
Pediatric blood & cancer
61.32
29
ENCERT: A Multisite Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide, and Etoposide in Relapsed T-Cell Lymphoblastic Leukemia/Lymphoma.
Pediatric blood & cancer
87.42
30
Advanced Radiotherapy Across a Multi-Geography Referral Network for Children With Ewing Sarcoma and Rhabdomyosarcoma: Treatment Delivery and Early Outcomes-A Single-Centre Experience.
Pediatric blood & cancer
72.88
31
Genomic Characterization of ETV6::RUNX1-Positive Childhood B-ALL in a Chinese Cohort: Novel Fusion Partners, Co-Occurring Mutations, and Risk-Stratifying Biomarkers.
Pediatric blood & cancer
59.75
32
Diagnostic Yield of Brain MRI in Pediatric Short Stature: Hypothalamic-Pituitary Lesions and Incidental Findings in Real-World Practice.
Clinical endocrinology
67.3